We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$2.7B
AUM Growth
+$27.7M
Cap. Flow
-$7M
Cap. Flow %
-0.26%
Top 10 Hldgs %
24.54%
Holding
474
New
12
Increased
115
Reduced
195
Closed
19

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$6.64M
2
MMM icon
3M
MMM
+$5.13M
3
CRM icon
Salesforce
CRM
+$4.32M
4
AMZN icon
Amazon
AMZN
+$3.46M
5
AVGO icon
Broadcom
AVGO
+$2.1M

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$6.15M
2
GE icon
GE Aerospace
GE
+$3.4M
3
WFC icon
Wells Fargo
WFC
+$2.56M
4
IBM icon
IBM
IBM
+$2.39M
5
AGN
Allergan plc
AGN
+$1.76M

Sector Composition

Rank Sector Weight
1 Healthcare 14.59%
2 Financials 14.1%
3 Technology 12.65%
4 Miscellaneous 11.5%
5 Industrials 11.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CME icon
226
CME Group
CME
$97.5B
$609K 0.02%
3,713
-100
-3% -$16.3K
BHP icon
227
BHP
BHP
$217B
$602K 0.02%
13,491
SHY icon
228
iShares 1-3 Year Treasury Bond ETF
SHY
$26.1B
$597K 0.02%
7,158
+1,139
+19% +$94.9K
ZBH icon
229
Zimmer Biomet
ZBH
$18.6B
$592K 0.02%
5,470
-234
-4% -$25.5K
GD icon
230
General Dynamics
GD
$97.7B
$587K 0.02%
3,150
SO icon
231
Southern Company
SO
$99.5B
$587K 0.02%
12,672
-50
-0.4% -$2.24K
DAL icon
232
Delta Air Lines
DAL
$51.7B
$571K 0.02%
11,525
+15
+0.1% +$800
VIG icon
233
Vanguard Dividend Appreciation ETF
VIG
$111B
$571K 0.02%
5,619
+965
+21% +$98.4K
VRTX icon
234
Vertex Pharmaceuticals
VRTX
$131B
$563K 0.02%
3,310
VO icon
235
Vanguard Morningstar Mid-Cap ETF
VO
$105B
$559K 0.02%
14,172
MMP
236
DELISTED
Magellan Midstream Partners, L.P.
MMP
$550K 0.02%
7,957
-86
-1% -$5.78K
ETR icon
237
Entergy
ETR
$49.1B
$544K 0.02%
13,470
-1,262
-9% -$50K
SCHF icon
238
Schwab International Equity ETF
SCHF
$68.8B
$541K 0.02%
32,744
+648
+2% +$11K
ELV icon
239
Elevance Health
ELV
$90.4B
$539K 0.02%
2,265
-50
-2% -$11.6K
VEA icon
240
Vanguard FTSE Developed Markets ETF
VEA
$235B
$538K 0.02%
12,552
+250
+2% +$11.1K
VTRS icon
241
Viatris
VTRS
$19.5B
$533K 0.02%
14,744
IJS icon
242
iShares S&P Small-Cap 600 Value ETF
IJS
$8.07B
$526K 0.02%
6,448
SLY
243
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
$517K 0.02%
7,156
LFUS icon
244
Littelfuse
LFUS
$10.3B
$513K 0.02%
2,250
ACWI icon
245
iShares MSCI ACWI ETF
ACWI
$32.8B
$501K 0.02%
7,040
VNQ icon
246
Vanguard Real Estate ETF
VNQ
$37.3B
$501K 0.02%
6,149
+337
+6% +$26.1K
IWD icon
247
iShares Russell 1000 Value ETF
IWD
$82.8B
$498K 0.02%
4,100
VB icon
248
Vanguard Morningstar Small-Cap ETF
VB
$78.8B
$498K 0.02%
3,202
VNO icon
249
Vornado Realty Trust
VNO
$6.61B
$495K 0.02%
6,696
E icon
250
ENI
E
$80.1B
$488K 0.02%
13,150
-1,250
-9% -$46.9K

Similar funds

Gofen & Glossberg's Q2 2018 Portfolio in Review

As of Q2 2018, Gofen & Glossberg held 474 positions worth $2.7B, up 1% from $2.67B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Gofen & Glossberg's Q2 2018 filing shows 12 new, 115 increased, 195 reduced and 19 closed positions. Its largest new stake was Evergy: 8,447 shares worth $474K. The largest sale was Monsanto Co, an estimated $6.15M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Financials and Technology.

  • Gofen & Glossberg's largest Q2 2018 buy was Evergy: 8,447 shares worth $474K.
  • Gofen & Glossberg added most to DuPont de Nemours in Q2 2018, an estimated $6.64M increase.
  • Gofen & Glossberg's biggest Q2 2018 reduction was GE Aerospace, cutting an estimated $3.4M.
  • Gofen & Glossberg fully exited Monsanto Co in Q2 2018, selling an estimated $6.15M.
  • Gofen & Glossberg's ten largest holdings make up 25% of its $2.7B portfolio in Q2 2018.
  • Gofen & Glossberg opened 12 new positions and closed 19 in Q2 2018.
  • Gofen & Glossberg's portfolio value rose 1% quarter-over-quarter to $2.7B.

Based on Gofen & Glossberg's 13F filing for Q2 2018, filed 11 Jul 2018.